Abzyme Therapeutics
Sarah B. has worked for Abzyme Therapeutics as a Scientist, specifically in the Partnerships & Collaboration department since July 2022. Prior to that, they worked at Eurofins from May 2020 to July 2021 as a Deviation Management Author.
Sarah B. holds a Ph.D. in Biochemistry from Rutgers University. Prior to that, they completed their Bachelor of Science (BS) in Political Science from the University of Houston. The specific start and end dates for both degrees were not provided.
This person is not in any teams
Abzyme Therapeutics
Abzyme Therapeutics is a biopharmaceutical company focused on developing modular single domain VHH antibody fragments for immunotherapy using proprietary antibody generation platforms.